Stoke Therapeutics (STOK) Current Assets: 2022-2025
Historic Current Assets for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to $272.4 million.
- Stoke Therapeutics' Current Assets rose 7.42% to $272.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $272.4 million, marking a year-over-year increase of 7.42%. This contributed to the annual value of $232.8 million for FY2024, which is 8.09% up from last year.
- According to the latest figures from Q3 2025, Stoke Therapeutics' Current Assets is $272.4 million, which was up 0.91% from $270.0 million recorded in Q2 2025.
- Over the past 5 years, Stoke Therapeutics' Current Assets peaked at $375.7 million during Q1 2025, and registered a low of $193.3 million during Q1 2024.
- For the 3-year period, Stoke Therapeutics' Current Assets averaged around $259.7 million, with its median value being $253.6 million (2024).
- In the last 5 years, Stoke Therapeutics' Current Assets decreased by 28.48% in 2024 and then spiked by 94.40% in 2025.
- Over the past 4 years, Stoke Therapeutics' Current Assets (Quarterly) stood at $244.1 million in 2022, then decreased by 11.77% to $215.3 million in 2023, then rose by 8.09% to $232.8 million in 2024, then climbed by 7.42% to $272.4 million in 2025.
- Its Current Assets was $272.4 million in Q3 2025, compared to $270.0 million in Q2 2025 and $375.7 million in Q1 2025.